25.01.2024  16:25:52 Изменение - Объем сделки Бид- Предложение- Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
51.6000USD - 912
Оборот: 47,059.2000
-Величина цены спроса: - -Величина цены предложения: - 11.28 млрдUSD - -

Описание деятельности

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
 

Правление & Наблюдательный совет

Исполнительный директор
Robert Koremans
Правление
Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton
Наблюдательный совет
Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò
 

Данные компании

Имя: Recordati S.p.A.
Адрес: via M. Civitali 1,I-20148 Milano
Телефон: +39-02-48787-1
Факс: +39-02-40073-747
E-mail: -
Интернет: www.recordati.com/
Индустрия: Healthcare
Сектор: Pharmaceutical Industry
Подсектор: Pharmaceuticals
Конец финансового года: 31.12
Акции в свободном обращении: 46.40%
Дата IPO: 01.01.1984

Связи с инвесторами

Имя: Marianne Tatschke
IR телефон: -
IR-факс: +39-02-48787-225
IR e-mail: inver@recordati.it

Календарь компании

CW 21 | 20.05.2024 Ex-Dividend
CW 21 | 21.05.2024 Record Date
CW 21 | 22.05.2024 Dividend Payment
CW 31 | 30.07.2024 Interim Report 2nd Quarter/6 Months
CW 45 | 08.11.2024 Interim Report 3rd Quarter/9 Months
 

Основные акционеры

CVC Capital Partners
 
51.80%
Другие
 
48.20%